John F Tisdale, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
17
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
9 more share only the name and are not shown
Trial papers
0
PubMed author-name match
Trials
Studies that name John F Tisdale, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:33 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07599176 · Partial Stem Cell Transplant for Sickle Cell Disease From Matched DonorsNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Sickle Cell Disease, Beta-thalassemia · principal investigator
- Early Ph1NCT06313398 · Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin LabelingNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Sickle Cell Disease, Thalassemia, Hemoglobinopathy · principal investigator
- Ph1/Ph2NCT05357482 · Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-ThalassemiaNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Sickle Cell Anemia, Beta Thalassemia · principal investigator
- Early Ph1NCT04476277 · Red Cell Half Life Determination in Patients With and Without Sickle Cell DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease, Sickle Cell Anemia · principal investigator
- N/ANCT04349189 · Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease, Venous Thrombosis, Sickle Cell Trait · principal investigator
- Ph1NCT03226691 · Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) PatientsNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease · principal investigator
- N/ANCT01547793 · Carbon Monoxide Levels and Sickle Cell Disease SeverityNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease, Sickle Cell Anemia, Anemia, Sickle Cell · principal investigator
- Ph2NCT00508989 · Niacin to Improve Blood Flow in People With Sickle Cell DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease · principal investigator
- Ph1NCT00352430 · Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary HypertensionNational Heart, Lung, and Blood Institute (NHLBI) · completed · Pulmonary Hypertension · principal investigator
- Ph1NCT00270478 · Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease, Chronic Kidney Disease, Pulmonary Hypertension · principal investigator
- Ph1NCT00095472 · Therapeutic Application of Intravascular Nitrite for Sickle Cell DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Anemia · principal investigator
- Ph1NCT00072826 · Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell DiseaseNational Institutes of Health Clinical Center (CC) · completed · Sickle Cell Disease · principal investigator
- Ph1/Ph2NCT00061568 · Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital AnemiasNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Congenital Hemolytic Anemia, Sickle Cell Disease · principal investigator
- Ph1NCT00056433 · Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell AnemiaNational Institutes of Health Clinical Center (CC) · completed · Sickle Cell Anemia · principal investigator
- N/ANCT00033774 · Stem Cell Collection for Adult VolunteersNational Heart, Lung, and Blood Institute (NHLBI) · terminated · Sickle Cell · principal investigator
- Ph1NCT00023296 · Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Anemia, Pulmonary Hypertension · principal investigator
- N/ANCT00012545 · Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · completed · Sickle Cell Disease, Sickle Cell Trait · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.